Endari treatment ameliorates sickle cell-related disruption in intestinal barrier functions and is associated with prolonged survival in sickle cell mice

CONCLUSION: Our findings provide the evidence supporting the beneficial effects of Enadri in improving intestinal barrier function and associated survival outcomes in SCD.PMID:38526293 | DOI:10.1080/16078454.2024.2331940

Source: Hematology - March 25, 2024 Category: Hematology Authors: Elio Haroun Seah H Lim Dibyendu Dutta Source Type: research